EMA's CHMP names vice-chair
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's committee for medicinal products for human use (CHMP) has elected Dr Pierre Demolis as vice-chair, for a three-year mandate. Dr Demolis – a cardiologist by training – is currently director of the oncology and hematology division at ANSM, the French medicines agency. He has been a member of the CHMP since 2007. Dr Demolis will replace Dr Ian Hudson in the role; Dr Hudson became the chief executive of the UK regulatory agency, the MHRA, in September this year. Meanwhile, Sweden's Dr Tomas Salmonson remains the committee chair, having been elected in 2012 for a three-year period.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.